Matches in Wikidata for { <http://www.wikidata.org/entity/Q93193835> ?p ?o ?g. }
Showing items 1 to 42 of
42
with 100 items per page.
- Q93193835 description "2018 թվականի նոյեմբերի 10-ին հրատարակված գիտական հոդված" @default.
- Q93193835 description "article scientifique publié en 2018" @default.
- Q93193835 description "artículu científicu espublizáu en payares de 2018" @default.
- Q93193835 description "bài báo khoa học" @default.
- Q93193835 description "scientific article published on 10 November 2018" @default.
- Q93193835 description "wetenschappelijk artikel" @default.
- Q93193835 description "наукова стаття, опублікована в листопаді 2018" @default.
- Q93193835 name "Design, synthesis and biological evaluation of novel, orally bioavailable pyrimidine-fused heterocycles as influenza PB2 inhibitors" @default.
- Q93193835 name "Design, synthesis and biological evaluation of novel, orally bioavailable pyrimidine-fused heterocycles as influenza PB2 inhibitors" @default.
- Q93193835 type Item @default.
- Q93193835 label "Design, synthesis and biological evaluation of novel, orally bioavailable pyrimidine-fused heterocycles as influenza PB2 inhibitors" @default.
- Q93193835 label "Design, synthesis and biological evaluation of novel, orally bioavailable pyrimidine-fused heterocycles as influenza PB2 inhibitors" @default.
- Q93193835 prefLabel "Design, synthesis and biological evaluation of novel, orally bioavailable pyrimidine-fused heterocycles as influenza PB2 inhibitors" @default.
- Q93193835 prefLabel "Design, synthesis and biological evaluation of novel, orally bioavailable pyrimidine-fused heterocycles as influenza PB2 inhibitors" @default.
- Q93193835 P1433 Q93193835-14FBF4FA-69C3-4C12-8238-0B64ACF15521 @default.
- Q93193835 P1476 Q93193835-EFC06D39-E478-414C-80EB-FF2CC2EC5548 @default.
- Q93193835 P2093 Q93193835-61318E9A-0B44-4AF2-9840-962EABE66908 @default.
- Q93193835 P2093 Q93193835-7C159689-E963-4401-81D0-01EDC4C8F2B9 @default.
- Q93193835 P2093 Q93193835-B033448C-61FB-4910-B4AD-F96532483EFD @default.
- Q93193835 P2093 Q93193835-B29F9B11-39A2-424A-98F4-2FDF5286A206 @default.
- Q93193835 P2093 Q93193835-B324F139-0ADC-4E83-9A7E-598F7B28B324 @default.
- Q93193835 P304 Q93193835-103BC95D-F6C9-497C-BE5A-EB1409B40EC0 @default.
- Q93193835 P31 Q93193835-2BD86A6B-06CB-4D87-B76F-AB617B2DE739 @default.
- Q93193835 P356 Q93193835-0C7D4C5A-937E-432E-AD68-D06E5DED953E @default.
- Q93193835 P478 Q93193835-021D2D2A-6779-4E88-99FC-F6A8A31FD52F @default.
- Q93193835 P577 Q93193835-A3A15CEB-8931-4AD9-9BA9-458A6EEDAB92 @default.
- Q93193835 P698 Q93193835-33499062-CD56-4F91-AB8B-4A788E4B5A85 @default.
- Q93193835 P356 J.EJMECH.2018.11.015 @default.
- Q93193835 P698 30448415 @default.
- Q93193835 P1433 Q3008624 @default.
- Q93193835 P1476 "Design, synthesis and biological evaluation of novel, orally bioavailable pyrimidine-fused heterocycles as influenza PB2 inhibitors" @default.
- Q93193835 P2093 "Guoping Hu" @default.
- Q93193835 P2093 "Jian Xiong" @default.
- Q93193835 P2093 "Jianqi Li" @default.
- Q93193835 P2093 "Jingjing Wang" @default.
- Q93193835 P2093 "Weili Zhao" @default.
- Q93193835 P304 "249-265" @default.
- Q93193835 P31 Q13442814 @default.
- Q93193835 P356 "10.1016/J.EJMECH.2018.11.015" @default.
- Q93193835 P478 "162" @default.
- Q93193835 P577 "2018-11-10T00:00:00Z" @default.
- Q93193835 P698 "30448415" @default.